“CONSEQUENCES OF ABRUPT DISCONTINUATION OF ANTI TUBERCULAR THERAPY (ATT) DUE TO ADVERSE DRUG REACTION (ADRS): A TERTIARY HOSPITAL BASED STUDY” (2026) PharmaNexus Bulletin, 2(2), pp. 1–5. Available at: https://lapinjournals.com/index.php/pnb/article/view/208 (Accessed: 27 August 2026).